Farraye FA - Search Results

1

Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement.

Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Wasan SK, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2014 Feb;20(2):246-50. doi: 10.1097/01.MIB.0000437737.68841.87. Inflamm Bowel Dis. 2014. PMID: 24374881 Free PMC article.

2

Management of neoplastic polyps in inflammatory bowel disease.

Friedman S, Odze RD, Farraye FA. Friedman S, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2003 Jul;9(4):260-6. doi: 10.1097/00054725-200307000-00006. Inflamm Bowel Dis. 2003. PMID: 12902849 Review.

3

Can regular use of 5-ASAs protect against the development of dysplasia and colorectal cancer in patients with ulcerative colitis?

Gitin Y, Farraye FA. Gitin Y, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2007 Aug;13(8):1051-2. doi: 10.1002/ibd.20154. Inflamm Bowel Dis. 2007. PMID: 17427239 No abstract available.

4

Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.

Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ; Crohn's and Colitis Foundation of America Clinical Alliance. Isaacs KL, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2007 Oct;13(10):1250-5. doi: 10.1002/ibd.20187. Inflamm Bowel Dis. 2007. PMID: 17567869 Clinical Trial.

5

Hyperactivated B cells in human inflammatory bowel disease.

Noronha AM, Liang Y, Hetzel JT, Hasturk H, Kantarci A, Stucchi A, Zhang Y, Nikolajczyk BS, Farraye FA, Ganley-Leal LM. Noronha AM, et al. Among authors: farraye fa. J Leukoc Biol. 2009 Oct;86(4):1007-16. doi: 10.1189/jlb.0309203. Epub 2009 Jul 9. J Leukoc Biol. 2009. PMID: 19589946 Free PMC article.

6

Do 5-ASAs prevent colorectal neoplasia in patients with ulcerative colitis? Still no answers.

Wasan SK, Farraye FA. Wasan SK, et al. Among authors: farraye fa. Inflamm Bowel Dis. 2010 Feb;16(2):358-60. doi: 10.1002/ibd.21065. Inflamm Bowel Dis. 2010. PMID: 19685451 No abstract available.

7

A practical guide to vaccinating the inflammatory bowel disease patient.

Wasan SK, Baker SE, Skolnik PR, Farraye FA. Wasan SK, et al. Among authors: farraye fa. Am J Gastroenterol. 2010 Jun;105(6):1231-8. doi: 10.1038/ajg.2009.733. Epub 2010 Jan 26. Am J Gastroenterol. 2010. PMID: 20104218 Review.

8

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T 3rd, McLeod R, Burgart LJ, Allen J, Brill JV; AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. Farraye FA, et al. Gastroenterology. 2010 Feb;138(2):738-45. doi: 10.1053/j.gastro.2009.12.037. Gastroenterology. 2010. PMID: 20141808 No abstract available.

9

AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Farraye FA, Odze RD, Eaden J, Itzkowitz SH. Farraye FA, et al. Gastroenterology. 2010 Feb;138(2):746-74, 774.e1-4; quiz e12-3. doi: 10.1053/j.gastro.2009.12.035. Gastroenterology. 2010. PMID: 20141809 Review. No abstract available.

10

A 24-year-old patient with Crohn's disease starting immunosuppressive therapy: vaccination issues to consider.

Wasan SK, Skolnik PR, Farraye FA. Wasan SK, et al. Among authors: farraye fa. Clin Gastroenterol Hepatol. 2010 Dec;8(12):1013-6. doi: 10.1016/j.cgh.2010.07.001. Epub 2010 Jul 23. Clin Gastroenterol Hepatol. 2010. PMID: 20656060 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

385 results

Search Page